2009 Fiscal Year Final Research Report
New gene therapy of Smad7 for hepatocellular carcinoma with liver cirrhosis
| Project/Area Number |
19790949
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | Wakayama Medical University |
|---|
Principal Investigator |
OZAWA Satoru Wakayama Medical University, 医学部, 助教 (40433354)
|
|---|
| Project Period (FY) |
2007 – 2009
|
| Keywords | 肝切除術 / 肝硬変 / 肝再生 / アデノウイルスベクター / TGF-β / Smad7 |
|---|
| Research Abstract |
In a cirrhotic liver, the regenerative ability and specific functions are impaires ; a hepatic resection increases the possibility of postoperative liver failure. A truncated type II transforming growth factor-β receptor (TβTR), which specifically inhibits TGF-β signaling as a dominant-negative receptor, appears to prevent the progression of liver fibrosis. We demonstrated the therapeutic efficacy of adenovirus-mediated TβTR gene transducation after partial hepatectomy for liver cirrhosis. Rats were treated with dimethylnitrosamine for 3 weeks, and they all had severe cirrhosis. After the 10% partial hepatectomy in rats of this model, we injected PBS, AdLacZ, and Ad TβTR, into the portal vein, which was followed by an additionl 2-week dimethylnitrosamine treatment. On histologic examination, fibrotic tissue had decreased in the livers of the Ad TβTR -treated rats compared with rats that were treated by PBS and AdLacZ. Ad TβTR treatment improved the survival rate after a partial hepatectomy. Our results suggest that the TβTR gene therapy may increase the possibility of hepatectomy in a cirrhotic liver by improving fibrosis, hepatic function, and hepatocyte regeneration.
|
Research Products
(1 results)
